In this regard, it has been demonstrated that SP1 is frequently upregulated in HNSCC and that a combined inhibition of SP1, using mithramycin, and TGFβ pathways induced cell death and prevented HNSCC recurrence [44]. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.